Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial

BACKGROUND: Treatment with bisphosphonates decreases bone loss and can increase disease-free survival in patients with breast cancer. The aim of our study was to assess the effect of zoledronic acid on clearance of disseminated tumour cells (DTCs) from the bone marrow in women undergoing neoadjuvant...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Aft, Rebecca, Naughton, Michael, Trinkaus, Kathryn, Watson, Mark, Ylagan, Lourdes, Chavez-MacGregor, Mariana, Zhai, Jing, Kuo, Sacha, Shannon, William, Diemer, Kathryn, Herrmann, Virginia, Dietz, Jill, Ali, Amjad, Ellis, Matthew, Weiss, Peter, Eberlein, Timothy, Ma, Cynthia, Fracasso, Paula M, Zoberi, Imran, Taylor, Marie, Gillanders, William, Pluard, Timothy, Mortimer, Joanne, Weilbaecher, Katherine
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3792651/
https://ncbi.nlm.nih.gov/pubmed/20362507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(10)70054-1
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller